Jules P P Meijerink Selected Research

Jules P P Meijerink Research Topics

Disease

28	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 02/2003
21	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2023 - 06/2006
8	Leukemia 01/2022 - 10/2010
7	Neoplasms (Cancer) 01/2023 - 05/2013
4	Glucocorticoid Receptor Deficiency 05/2007 - 08/2005
3	Neuroblastoma 10/2013 - 10/2011
2	Lymphoma (Lymphomas) 01/2019 - 01/2012
2	T-Cell Leukemia (Leukemia, T Cell) 01/2014 - 11/2010
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2021
1	Splenomegaly 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 06/2017
1	Aneuploidy (Aneuploid) 06/2017
1	Primitive Neuroectodermal Tumors (PNET) 10/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2013
1	Infections 05/2013
1	Ganglioneuroblastoma 03/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2011
1	Hematologic Neoplasms (Hematological Malignancy) 10/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2006
1	Colitis 07/2006

Drug/Important Bio-Agent (IBA)

6	Messenger RNA (mRNA)IBA 10/2011 - 02/2003
5	SteroidsIBA 01/2024 - 12/2016
5	GlucocorticoidsIBA 01/2023 - 08/2005
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 07/2009
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021 - 08/2005
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2008
4	Asparaginase (Elspar)FDA Link 10/2010 - 04/2003
4	Prednisolone (Predate)FDA LinkGeneric 10/2010 - 04/2005
3	Phosphotransferases (Kinase)IBA 01/2022 - 01/2016
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2014 - 04/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 12/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016 - 07/2014
2	TensinsIBA 01/2016 - 07/2014
2	Small Interfering RNA (siRNA)IBA 05/2013 - 05/2008
2	Anaplastic Lymphoma KinaseIBA 03/2012 - 10/2011
2	Protein Isoforms (Isoforms)IBA 01/2012 - 09/2005
2	EnzymesIBA 08/2011 - 02/2003
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2024
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 11/2023
1	V 70 (V70)IBA 11/2023
1	Parathyroid Hormone (Parathormone)IBA 01/2023
1	CCCTC-Binding FactorIBA 01/2023
1	Diphosphonates (Bisphosphonates)IBA 01/2023
1	Protein Kinase InhibitorsIBA 01/2022
1	ruxolitinibIBA 12/2021
1	AZD 6244IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Complement Factor B (Factor B)IBA 01/2019
1	venetoclaxIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	NTRC 0066-0IBA 06/2017
1	2- (4- morpholinoanilino)- 6- cyclohexylaminopurineIBA 06/2017
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 12/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2016
1	Decitabine FDA Link 10/2013
1	Drug CombinationsIBA 10/2013
1	theasinensin AIBA 10/2013
1	trichostatin A (A 300)IBA 10/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2013
1	9-arabinofuranosylguanineIBA 08/2011
1	NucleosidesIBA 08/2011
1	nelarabine (506U78)FDA Link 08/2011
1	forodesineIBA 08/2011
1	Homeodomain Proteins (Proteins, Homeobox)IBA 11/2010
1	MicroRNAs (MicroRNA)IBA 10/2010
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2010
1	CytokinesIBA 06/2010
1	Protein Tyrosine PhosphatasesIBA 06/2010
1	multidrug resistance-associated protein 1IBA 12/2008
1	Differentiation AntigensIBA 12/2008
1	ras ProteinsIBA 04/2008
1	Neurofibromin 1 (Neurofibromin)IBA 04/2008
1	MucinsIBA 07/2006
1	Dextran SulfateIBA 07/2006
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 06/2006
1	Vincristine (Oncovin)FDA LinkGeneric 04/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2003

Therapy/Procedure

7	Therapeutics 01/2021 - 09/2006
2	Drug Therapy (Chemotherapy) 01/2023 - 12/2019
1	Heterologous Transplantation (Xenotransplantation) 07/2014
1	Combination Drug Therapy (Combination Chemotherapy) 12/2008